PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsB-cell chronic lymphocytic leukemia
MeSH D015451 - b-cell chronic lymphocytic leukemia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D002908:Chronic disease
0 Companies
0 Drugs
Success rate
D015448:B-cell leukemia
0 Companies
0 Drugs
Success rate
D015451: 
B-cell chronic lymphocytic leukemia
44 Companies
18 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaIfosfamide, Mesna Ifosfamide/mesna  2002-02-26   
Cyclophosphamide Neosar  1993-04-29   
Dr Reddys LaboratoriesCyclophosphamide Cyclophosphamide 2036-02-15 2020-07-30   
MylanCladribine Cladribine  2011-10-06   
Rising PharmaceuticalsFludarabine Fludarabine  2011-12-21   
Ifosfamide Ifosfamide  2012-11-26   
Johnson & JohnsonIbrutinib Imbruvica  2014-10-21 $3,095 M Q4/23-Q3/24 
Cladribine Leustatin  1993-02-26   
RocheObinutuzumab Gazyvaro  2014-07-22   
Rituximab MabThera  1998-06-02   
CiplaCyclophosphamide Cyclophosphamide  2019-01-18   
SandozFludarabine Fludarabine  2007-09-21   
Rituximab Rixathon  2017-06-15   
Cyclophosphamide Cyclophosphamide  2023-09-12   
AbbVieVenetoclax Venclyxto  2016-12-04   
AstraZenecaAcalabrutinib Calquence  2020-11-05 $1,455 M Q2/21-Q2/24 
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
60%
129/216
Phase 2
27%
50/188
Phase 3
57%
40/70
Approved: 20Overall Success rate: 9%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Cyclophosphamide,
Hsct,
Ptcy
Mylan
Mercaptopurine
Johnson & Johnson
Ibrutinib,
Ademetionine,
Doconexent,
Aspartame,
Bevifimod,
DUVORTUXIZUMAB,
Mk3475,
Microgynon,
Wellbutrin,
Zyban,
Abt199
Roche
Rituximab,
Obinutuzumab,
Antithrombin iii,
Edrecolomab,
Doconexent,
Terfenadine,
Sodium lactate,
Aspartame,
Bevifimod,
Microcrystalline cellulose,
Corticoids,
Btki,
Hsct,
Arm1,
Cc5013,
Abt199
Sandoz
Rituximab
AbbVie
Venetoclax,
Antithrombin iii,
Navitoclax,
Ademetionine,
Doconexent,
Bevifimod,
Muromonab-cd3,
Caelyx,
Doxorubin,
Ibi301,
Gemox,
Arm1,
Hydroxydaunomycin,
Arm2,
Cc5013,
Cmab819,
Evidence,
Abt199,
Tqb2303
AstraZeneca
Acalabrutinib,
Doconexent,
Ceralasertib,
Bevifimod,
Palifosfamide,
Caelyx,
Doxorubin,
Iphosphamid,
Vp16,
Azd0486,
Btki,
Hsct,
Hydroxydaunomycin,
AZD4573,
Evidence,
Abt199
Novartis
Ofatumumab,
Benzocaine,
Antithrombin iii,
Buparlisib,
Ademetionine,
Doconexent,
Genistein,
Ianalumab,
Sodium lactate,
Afuresertib,
Aspartame,
Bevifimod,
LUCATUMUMAB,
SOTRASTAURIN,
Microcrystalline cellulose,
Corticoids,
JBH492,
Hdmp,
Solumedrol,
Sti571,
Arm1,
Arm2,
Cc5013,
Pbo
Sanofi
Alemtuzumab,
Fludarabine,
Fludarabine phosphate,
Mycophenolate sodium,
Antithrombin iii,
Ademetionine,
Sodium lactate,
ALVOCIDIB,
Bevifimod,
VOXTALISIB,
Microcrystalline cellulose,
Ratg,
Vp16,
Hsct,
Arm1,
Arm2,
Cc5013,
Evidence
Merck & Co
Dinaciclib,
Ademetionine,
Zilovertamab,
Sodium lactate,
Bevifimod,
Microcrystalline cellulose,
Retinol,
Cirmtuzumab,
Mk0752,
Mk3475,
Abt199
Pfizer
Rituximab,
Agatolimod,
Aspartame,
Pf03512676,
Arm1,
Arm2
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use